In 2015, tumor-derived MSCs from acute myeloid leukemia and lung cancer tissues and cells cultured in conditioned media from HeLa cells were reported to present a higher expression of TLR4 compared to unsorted MSCs [66]. The gene discussed is TLR4; the disease is acute myeloid leukemia.